INVXEnergy · Oil & Gas Equipment & ServicesThe 5 Wall Street analysts covering Innovex International, Inc. hold a median 12-month price target of $35 — +23.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 92 of 100 as at 1 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Innovex International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (97): Analysts have, on balance, been raising their forecasts.
Growth (40): Sales and profits are flat, shrinking, or growing more slowly than they were.
Size (36): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own Innovex International, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on INVX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +23.7% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 8 June 2026 | Jefferies | Initiates | Buy | $34 |
| 8 June 2026 | Jefferies | Initiates | Buy | — |
| 18 May 2026 | Piper Sandler | Maintains | Overweight | — |
| 8 May 2026 | Barclays | Maintains | Equal-Weight | — |
| 7 May 2026 | Citigroup | Initiates | Buy | — |
| 3 Mar 2026 | Barclays | Maintains | Equal-Weight | — |
| 18 Dec 2025 | Piper Sandler | Maintains | Overweight | — |
| 14 Nov 2025 | Barclays | Upgrade | Equal-Weight | — |
| 15 July 2025 | Piper Sandler | Initiates | Overweight | — |
| 9 May 2025 | Barclays | Maintains | Underweight | — |
| 5 Mar 2025 | Barclays | Maintains | Underweight | — |
| 26 Nov 2024 | Barclays | Maintains | Underweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 21% of US stocks
Cheaper than 52% of US stocks
Cheaper than 47% of US stocks
Cheaper than 38% of US stocks
Higher than 28% of US stocks
Higher than 31% of US stocks
Higher than 45% of US stocks
Higher than 70% of US stocks
Higher than 61% of US stocks
Higher than 54% of US stocks
Higher than 80% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. INVX appears on the weeks it earns a place.
Innovex International (INVX) reported Q2 earnings of $0.36 per share, surpassing the Zacks Consensus Estimate of $0.30 per share and up from $0.28 per share in the same quarter last year.
Why it matters — The earnings beat signals that the company's recent financial performance exceeded analyst expectations and improved year over year.
The 5 Wall Street analysts covering Innovex International, Inc. have a median 12-month price target of $35, with estimates ranging from $26 to $35. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 5 analysts covering Innovex International, Inc., 4 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Innovex International, Inc. 92 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, Innovex International, Inc. ranks 92 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (97 of 100).
No one can know that. What the data says: the median 12-month target from 5 analysts implies +23.7% from the last close, and Ticker Nerd's factor model ranks Innovex International, Inc. 92 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Innovex International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for INVX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $26 to $35 over the next 12 months.
Innovex International, Inc. returned +79.5% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Innovex International Inc. operates as a dynamic player in the chemical industry, focusing on the development, manufacture, and distribution of a broad spectrum of specialty chemicals.
The most recent item we track (Zacks Investment Research, 3 Aug 2026): "Innovex International (INVX) Q2 Earnings and Revenues Top Estimates". Innovex International (INVX) reported Q2 earnings of $0.36 per share, surpassing the Zacks Consensus Estimate of $0.30 per share and up from $0.28 per share in the same quarter last year.
Innovex International Inc. operates as a dynamic player in the chemical industry, focusing on the development, manufacture, and distribution of a broad spectrum of specialty chemicals. Its primary function is to supply advanced chemical solutions that cater to a diverse array of sectors, including automotive, electronics, pharmaceuticals, and agriculture. Notable for its innovative approach, Innovex International invests heavily in research and development to create unique formulations that address specific industrial challenges, enhancing product performance and sustainability. The company is instrumental in manufacturing processes that require precise chemical modifications, contributing significantly to the value chain within these sectors. Innovex International's products often serve as critical components that enhance the functional properties of end products, thereby playing a crucial role in the effectiveness and efficiency of various industrial applications. By maintaining a robust portfolio geared towards cutting-edge technological advancements and environmental considerations, Innovex International holds a pivotal position in shaping industry standards and meeting the evolving demands of global markets.
CEO Mr. Adam B. Anderson · 2,160 employees · United States · https://www.innovex-inc.com